Skip to main content

Erlotinib

NDC 68382-915 · Zydus Pharmaceuticals USA Inc.

Generic nameErlotinib
Dosage formTABLET
RouteORAL
Active ingredient(s)ERLOTINIB HYDROCHLORIDE
Strength150 mg/1
Pharmacologic classKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
Marketing categoryANDA

Packages

68382-915-06 — 30 TABLET in 1 BOTTLE (68382-915-06)

68382-915-16 — 90 TABLET in 1 BOTTLE (68382-915-16)

68382-915-84 — 3 BLISTER PACK in 1 CARTON (68382-915-84) / 10 TABLET in 1 BLISTER PACK (68382-915-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-565 — ERLOTINIB HYDROCHLORIDE, 46708-566 — ERLOTINIB HYDROCHLORIDE, 46708-567 — ERLOTINIB HYDROCHLORIDE, 59651-530 — Erlotinib, 59651-531 — Erlotinib, 59651-532 — Erlotinib, 62332-565 — ERLOTINIB HYDROCHLORIDE, 62332-566 — ERLOTINIB HYDROCHLORIDE, 62332-567 — ERLOTINIB HYDROCHLORIDE, 68382-913 — Erlotinib, 68382-914 — Erlotinib, 70771-1521 — Erlotinib, 70771-1522 — Erlotinib, 70771-1523 — Erlotinib, 72205-080 — Erlotinib Hydrochloride, 72205-081 — Erlotinib Hydrochloride, 72205-082 — Erlotinib Hydrochloride, 72485-217 — Erlotinib hydrochloride, 72485-218 — Erlotinib hydrochloride, 72485-219 — Erlotinib hydrochloride, +6 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.